COSCO SHIP PORT (01199) reported that profit attributable to shareholders for the first three quarters rose 19.7% year on year to US$316 million.
COSCO SHIPPING Ports (01199) announced that for the three months ended September 30, 2026, total throughput rose 8.4% year on year to 42.2666 million TEU; equity throughput rose 8.1% year on year to 12.8846 million TEU; the company's revenue rose 13.0% year on year to US$484 million; profit attributable to equity holders of the company rose 0.1% year on year to US$82.589 million; basic earnings per share were 2.06 US cents.
COSCO SHIP PORT (01199) announced that for the 3 months ended September 30, 2026, total throughput rose 8.4% year on year to 42.2666 million TEU; equity throughput rose 8.1% year on year to 12.8846 million TEU; the company's revenue rose 13.0% year on year to US$484 million; profit attributable to equity holders of the company rose 0.1% year on year to US$82.589 million; basic earnings per share were 2.06 US cents.
For the 9 months ended September 30, 2026, total throughput rose 8.1% year on year to 122 million TEU; equity throughput rose 7.4% year on year to 37.3766 million TEU; the company's revenue rose 12.6% year on year to US$1.39 billion; profit attributable to equity holders of the company rose 19.7% year on year to US$316 million; basic earnings per share were 7.95 US cents.
Related Articles

SHOUCHENG (00697) repurchased 5.55 million shares on October 29 for HK$6.659 million.

ZERO2IPO (01945) repurchased 2,000 shares on October 29 for HK$2,598.

DAWNRAYS PHARMA (02348) repurchased 44,000 shares for HK$40,500 on October 29.
SHOUCHENG (00697) repurchased 5.55 million shares on October 29 for HK$6.659 million.

ZERO2IPO (01945) repurchased 2,000 shares on October 29 for HK$2,598.

DAWNRAYS PHARMA (02348) repurchased 44,000 shares for HK$40,500 on October 29.






